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Open access echocardiography (OAE) is defined as echocar-
diography that is requested by, reported to, and acted upon
by general practitioners (GPs). Echocardiography provides
information about cardiac anatomy (e.g. volumes, geometry,
mass) and function (e.g. left ventricular function and wall
motion, valvular function, right ventricular function, pulmo-
nary artery pressure, pericardium).
In the population referred by the GPs, the pretest likeli-
hood of disease is much lower than in the (prescreened)
hospital population. Thus OAE is mainly used as a screening
tool to exclude clinically relevant abnormalities.
The most common indications for OAE are assessment of
asymptomatic murmurs, breathlessness and suspected heart
failure. OAE is able to exclude significant valvular heart
disease, with the exception of dynamic, exercise-related
mitral regurgitation.
OAE is also valuable in a breathless patient if left
ventricular (LV) dysfunction (ejection fraction <40 %) is
found, leading to a management change, e.g. starting an
ACE inhibitor and β-blocker. However, a normal systolic
LV function in a breathless patient does not exclude a
cardiac cause of breathlessness, as this may be caused by
diastolic LV dysfunction, ischaemia or paroxysmal heart
rhythm problems. In such cases, the echocardiographic
examination needs to be interpreted in the context of
clinical history and examination, ECG, exercise ECG or
other tests.
Van Gurp et al. describe their experience with OAE,
which was set up independently from the regional hospitals
[1]. The aim of the study was to demonstrate that OAE
reduces the number of referrals to the cardiologist and found
a decrease in intended referrals within a mean follow-up of
4 months (92 % vs. 34 %, p<0.001). However, the aim of the
study should have been: reducing the number of referrals,
without compromising patient care. This means that one
should also investigate subsequent patient management
(change in medication), delayed referrals and hospitalisations.
Ideally, this should have been investigated in a randomised
controlled trial.
The indication for echocardiography (and potential refer-
ral to the cardiologist) in the present study was suspected
valve disease in the majority of cases and, less often,
suspected heart failure: 81 (55 %) and 55 (35 %), respective-
ly. However, one would expect a much higher number of
heart failure indications, as 54 GP practices participated.
Each year approximately 7 patients are expected to develop
heart failure for the first time in a Dutch average general
practice of 2350 patients. Therefore, the OAE indication of
suspected heart failure should have been 7 times higher, i.e.
circa 375 patients instead of 55 [2]. This underutilisation of
OAE in suspected heart failure is also obvious in other
studies [3–5].
What are the reasons for this underutilisation of OAE
for the indication of suspected heart failure?
Barriers to an accurate diagnosis include: lack of confidence
in interpreting the results of technical echo reports, inertia or
fear of initiating action because of anxieties about commit-
ting to an intensive course of action, such as investigations,
initiation, titration and monitoring of treatment, or patients’
choices, including reluctance to be investigated or treated
further [6].
According to the heart failure guideline of the Dutch
Association of General Practitioners, in case of suspected
heart failure first an ECG and NT-proBNP should be
performed. If the diagnosis of heart failure cannot be
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excluded by ECG and (NT-pro) BNP, echocardiography
should always be carried out for further diagnosis or to
determine the cause of heart failure. In the study by Van
Gurp et al., neither an ECG nor NT-proBNP were performed
before referral for OAE in 1:4 patients with suspected heart
failure, in 55 % NT-proBNP was performed and in 62 % an
ECG, indicating a suboptimal adherence to heart failure
guidelines.
Although it is important to diagnose heart failure, which
can be treated according to protocol by a GP, it is even more
important to assess and address the cause of heart failure. No
data are provided in the present study on the cause of heart
failure and how this was addressed.
Moreover, the present study provides no information on
patient treatment as a result of echocardiographic findings.
However, a cross-sectional observational study, in a repre-
sentative sample of 357 patients diagnosed with heart
failure from 42 GP practices in the Netherlands (mean
age 75 years, 77 % in NYHA class 1 or 2), found that
76.5 % of patients received diuretics. ACE inhibitors were
prescribed in 40.6 % and angiotensin-II receptor blockers
in 20.7 %; β-blockers were prescribed to 54.6 %, while
24.9 % received spironolactone. Only small percentages
(10–25 %) of patients received drugs in the suggested daily
target doses [7].
How to proceed with OAE?
Important issues for OAE are:
1) A local (regional or nationwide) consensus document
should be created, including generally accepted indica-
tions for OAE (e.g. suspected heart failure and assess-
ment of asymptomatic murmurs), the required pretest
information, the level of training of ultrasound techni-
cians, the way of reporting, and cardiologist advice for
further treatment. In this consensus document barriers to
be overcome before implementation of OAE in primary
and secondary care should be identified and addressed
[5]. Just as in the UK, it could turn out that not OAE, but
a rapid access one-stop heart failure clinic (independent
treatment centre) is the favoured model of care, offering
diagnosis and initial treatment, whilst liaising with GPs
and nurses for maintenance and palliative services [8]. In
the present study OAE was set up independently from
the regional hospitals, which does not seem the right
way to go.
2) The echocardiographic examination should be
performed by individuals with sufficient training
and accreditation in echocardiography. In the pres-
ent study it is stated that at first echocardiographic
examinations were suboptimal due to lack of
routine and experience of the ultrasound techni-
cians; their accreditation level is not mentioned.
3) Reports of OAE should contain a minimum of infor-
mation, relevant for treatment according to the guide-
lines. The report should be devoid of trivial abnor-
malities that confuse the GPs, such as mild thickening
of the aortic valve in the elderly or mild MR or TR.
All echo reports should be provided with a cardiolo-
gist’s advice. In order to give good advice, the cardi-
ologist needs information on relevant general and car-
diovascular history, medication, physical examination,
ECG and NT-proBNP. In the study by Van Gurp et al.
the cardiologists received insufficient information, i.e.
they only had access to the indication and patient-
reported height and weight. In case of heart failure also
the cause of heart failure should be searched for and
mentioned.
4) An intensive collaboration between first-line (GPs) and
second-line (cardiologists) is mandatory to prevent a
decrease in the quality of patient care, both as to optimal
treatment and in a search for the (potentially reversible)
cause of heart failure.
5) Additional research is necessary, preferably a randomised
controlled trial with clinical outcomes and cost-
effectiveness analysis.
Currently, in the Netherlands, OAE is the result of com-
petition in patient care and a perceived long waiting list for
referral to the cardiologist. However, for society, low-
threshold OAE might turn out to be more expensive due to
more unnecessary echocardiographic examinations.
Apart from that, the legal consequences of an unfavourable
clinical course after OAE are yet unclear.
The danger of OAE is that it leads to a ‘low-budget pseudo-
consult’ of the cardiologist, whilst the patient thinks he is
getting a state-of-the-art treatment.
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